INOSI
Live / Registered — Registered (as of 30 Apr 2024)
What this means for you
Registered since 30 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79368273
- Registration number
- 7369832
- Mark type
- Stylized text
- Filed
- 26 Mar 2023
- Published for opposition
- 13 Feb 2024
- Registered
- 30 Apr 2024
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of fibrosis, inflammatory and autoimmune disorders, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, pulmonary fibrosis, vascular fibrosis and cardiac fibrosis; pharmaceutical preparations for use in the treatment of systemic sclerosis, Sjogren's syndrome, Rheumatoid arthritis, and systemic lupus erythematosus; pharmaceutical preparations for use in the treatment of cancer and radiation induced lung injury; pharmaceutical preparations for use in the treatment of idiopathic pulmonary fibrosis, and pulmonary arterial hypertension; pharmaceutical preparations for use in the treatment of nonalcoholic steatohepatitis (NASH), fatty liver diseases and disorders and steatohepatitis and other related diseases and disorders
Owner
Prosecution history
- 10 Aug 2024 — NOTIFICATION PROCESSED BY IB
- 19 Jul 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Jul 2024 — FINAL DISPOSITION PROCESSED
- 30 May 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 30 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 Feb 2024 — NOTIFICATION PROCESSED BY IB
- 13 Feb 2024 — PUBLISHED FOR OPPOSITION
- 24 Jan 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 24 Jan 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 24 Jan 2024 — NOTICE OF PUBLICATION
- 08 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Dec 2023 — ASSIGNED TO EXAMINER
- 13 May 2023 — APPLICATION FILING RECEIPT MAILED
- 09 May 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 May 2023 — LIMITATION FROM ORIGINAL APPLICATION ENTERED